Biotechnology Stocks II Performance Guide: Stoke Therapeutics, Inc. (STOK)
STOK has no dividends.
Table and Chart of STOK Performance
See what a $1,000 investment in STOK is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| STOK Returns | |
|---|---|
| Start Date | Jul-31-2019 |
| Start Price | $24.64 |
| End Date | May-16-2024 |
| End Price | $14.03 |
| # Prices | 59 |
| Min Date | Nov-30-2023 |
| Min Price | $3.79 |
| Max Date | Dec-31-2020 |
| Max Price | $61.93 |
| Total Return | -43.06% |
| Annualized Return | -10.82% |
| Current Value of $1,000 Purchase | $569 |
| Number Returns | 1,711 |
| Average Return | -31.57% |
| Number Profitable Returns | 348 |
| Percent Profitable Returns | 20.34% |
| Number Unprofitable Returns | 1,363 |
| Percent Unprofitable Returns | 79.66% |
| Profitable to Unprofitable Returns Ratio | 0.26 |
| STOK Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $736,454,000 |
| Beta | 0.813 | Price to Sales | 75.43 |
| Earnings per Share | $-2.4200 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 4.15 |
| PRICE DATA | |
| 52 Week High | $16.4 |
| 52 Week Low | $3.35 |
| Analyst Target Price | $23.5 |
| 50-Day Moving Average | $10.69 |
| 200-Day Moving Average | $6.34 |
| FINANCIAL DATA | |
| Revenue per Share | $0.175 |
| Revenue | $7,844,000 |
| Profit Margin | 0% |
| Return on Equity | -61.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
STOK Compare Returns with S&P 500
STOK Trendline Chart
STOK Moving Average Chart
STOK Stock Return Map - See Patterns of Gains and Losses
STOK Stock Returns/Purchase Dates